Dr. Bharat Sachdeva, MD

Dr. Sachdeva practices at Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System.

Dr. Sachdeva's NPI, 1720098296, was assigned on August 8, 2006. Dr. Sachdeva holds Louisiana license 026348.

Dr. Sachdeva's primary practice is Ochsner LSU Health - Academic Medical Center, at 1541 Kings Highway, Shreveport, LA 71130 in Caddo Parish. The practice phone is (318) 675-5058.

Dr. Sachdeva's primary practice is Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System. Dr. Sachdeva is also affiliated with Ochsner LSU Health - St. Mary Medical Center. The medical group on file is LSU Health Shreveport. Dmand AI also links Dr. Sachdeva to 1 more hospital, 5 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sachdeva practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sachdeva's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sachdeva is licensed in Louisiana.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and parathyroid gland disorder among the conditions Dr. Sachdeva treats.

CMS data shows 525 Medicare services from Dr. Sachdeva across 14 procedure codes in 2024, for 204 Medicare patients. Medicare paid $48,876 for them.

CMS counts 204 Medicare patients who saw Dr. Sachdeva in 2024. The largest group is under 65, with 79 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 58% are also on Medicaid. Their average risk score is 6.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sachdeva's median patient age at 68, with 51% women.

In 2024, Dr. Sachdeva wrote 1,554 Medicare Part D claims for 225 patients. 81% of them were for generic drugs. CMS names the drug for 1,287 of them, across 38 drugs with 11 or more claims each, at $271,930 in total drug cost. In 2023, CMS named 1,247 claims across 37 drugs.

Dr. Sachdeva accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Sachdeva, published from 2009 to 2025. 2021 was the busiest year, with 2. The most frequent topics are Arteriovenous Shunt, Surgical, Renal Dialysis and Vascular Patency. Dr. Sachdeva has published most often in J Vasc Access. Dr. Sachdeva's most frequent co-authors are Kenneth Dominic Abreo, MBBS, Gerald A. Beathard, MD and George M. Nassar, MD.

Dmand AI links Dr. Sachdeva to 1 clinical trial. Conditions studied include Arteriovenous Fistula and Vascular Fistula. Open Payments lists research payments to Dr. Sachdeva that name 1 trial.

CMS Open Payments shows 310 general payments to Dr. Sachdeva from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 29% of the total. Relypsa, Inc. paid the most, $13,336. It also lists 4 research payments totaling $3,520 from 2017 to 2019, naming 1 clinical trial.

Dr. Sachdeva is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.